Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA 2 DS 2 -VASc score

Risk factors of left atrial thrombus (LAT) or spontaneous echo contrast (LASEC) in non-valvular atrial fibrillation (NVAF) had been reported. However, information in the subgroup of NVAF patients with low CHA DS -VASc scores was limited. Here, we evaluated the risk factors of LAT/LASEC in NVAF patie...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and thrombolysis Vol. 53; no. 2; p. 523
Main Authors Chen, Jindong, Zhou, Mengmeng, Wang, Hao, Zheng, Zhihuang, Rong, Wenwen, He, Ben, Zhao, Liang
Format Journal Article
LanguageEnglish
Published Netherlands 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Risk factors of left atrial thrombus (LAT) or spontaneous echo contrast (LASEC) in non-valvular atrial fibrillation (NVAF) had been reported. However, information in the subgroup of NVAF patients with low CHA DS -VASc scores was limited. Here, we evaluated the risk factors of LAT/LASEC in NVAF patients with low CHA DS -VASc scores. Transesophageal echocardiography (TEE) file of NVAF patients with low CHA DS -VASc scores was reviewed (between June 2009 and Feb 2019) in this retrospective observational study. Binary logistic regression analysis was performed to identify risk factors other than the CHA DS -VASc score. Propensity score matching (PSM) was used to further evaluate independent risk markers for LAT/LASEC. The newly discovered factors were added to the CHA DS -VASc score, and receiver operating characteristic analysis was used to evaluate the ability of the model to predict LAT/LASEC. TEE files of 3056 NVAF patients with low CHA DS -VASc scores were reviewed. Regression analysis revealed elevated fibrinogen and enlarged left atrium (LA) were risk factors for LAT/LASEC. Further PSM analysis confirmed that elevated fibrinogen and enlarged LA were independent risk factors for LAT/LASEC. After including fibrinogen and left atrial diameter (LAD), the CHA DS -VASc score was more accurate for LAT/LASEC prediction in NVAF patients with low CHA DS -VASc scores (area under the curve difference is 0.241, 95% confidence interval (CI) 0.188-0.294, Z = 8.890, P < 0.0001). Elevated fibrinogen and enlarged LA were independent risk factors for LAT/LASEC in NVAF patients with low CHA DS -VASc scores. Taking fibrinogen and LAD into consideration may help improve LAT/LASEC risk evaluation, which warrants further validation studies.
ISSN:1573-742X